业界动态国内医卫资讯

达格列净可能减少肝硬化患者的腹水

Medscape News · 2026-11-13 04:57

摘要

达格列净可能改善肝硬化及难治性腹水患者的腹水控制,并减少对腹腔穿刺和白蛋白使用的需求。Medscape Medical News

English
Dapagliflozin May Reduce Ascites in Patients With Cirrhosis

Dapagliflozin may improve ascites control in patients with cirrhosis and refractory ascites and reduce the need for paracentesis and albumin use. Medscape Medical News

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界